MedTrace Logo

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes

NCT01239589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1280

Last updated 2011-03-29

No results posted yet for this study

Summary

This study is being carried out to find out how patients suffering from the acute manic phase of bipolar disease are currently managed with Quetiapine Immediate Release (IR) or Quetiapine Extended Release (XR) in the hospital setting in real life practice, including length of stay.

Conditions

  • Acute Bipolar Manic Episode

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Belgium
  • Croatia
  • Denmark
  • Finland
  • Germany
  • Italy
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01239589 on ClinicalTrials.gov